Summary
MedPlus Health Services shares tumbled 16% after reporting a 21% year-on-year drop in Q1 profit, despite a 21.9% revenue growth to ₹1,880 crore. Brokerage Nomura maintained a 'Buy' rating, citing long-term growth potential from store expansion.